Dermagraft deal extended to venous applications
This article was originally published in Clinica
Executive Summary
Advanced Tissue Sciences and Smith & Nephew have expanded their 50:50 joint venture to include the development and marketing of Dermagraft for venous ulcers, pressure sores, burns and other wounds. The new agreement is valid worldwide except for the US and also covers the marketing of Dermagraft TC, a temporary covering for partial and full-thickness burns.